Werewolf Therapeutics, Inc.
HOWL
$0.7104
-$0.0822-10.37%
| Weiss Ratings | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.84 | |||
| Price History | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -31.03% | |||
| 30-Day Total Return | -48.52% | |||
| 60-Day Total Return | -54.17% | |||
| 90-Day Total Return | -60.09% | |||
| Year to Date Total Return | -54.46% | |||
| 1-Year Total Return | -88.16% | |||
| 2-Year Total Return | -71.81% | |||
| 3-Year Total Return | -84.92% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -88.50% | |||
| 52-Week Low % Change | 0.31% | |||
| Price | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $6.89 | |||
| 52-Week Low Price | $0.79 | |||
| 52-Week Low Price (Date) | Apr 03, 2025 | |||
| 52-Week High Price (Date) | Apr 29, 2024 | |||
| Valuation | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 35.53M | |||
| Enterprise Value | -38.38M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.65 | |||
| Earnings Per Share Growth | 57.83% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 18.74 | |||
| Price/Book (Q) | 0.48 | |||
| Enterprise Value/Revenue (TTM) | -20.36 | |||
| Price | $0.71 | |||
| Enterprise Value/EBITDA (TTM) | 0.53 | |||
| Enterprise Value/EBIT | 0.52 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 44.48M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617 952 0555 | |||
| Address | 200 Talcott Ave Watertown, MA 02472 | |||
| Website | werewolftx.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -3,904.19% | |||
| Profit Margin | -3,740.84% | |||
| Management Effectiveness | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -30.49% | |||
| Return on Equity | -- | |||
| Income Statement | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.89M | |||
| Total Revenue (TTM) | 1.89M | |||
| Revenue Per Share | $0.04 | |||
| Gross Profit (TTM) | -51.20M | |||
| EBITDA (TTM) | -71.78M | |||
| EBIT (TTM) | -73.59M | |||
| Net Income (TTM) | -70.52M | |||
| Net Income Avl. to Common (TTM) | -70.52M | |||
| Total Revenue Growth (Q YOY) | -100.00% | |||
| Earnings Growth (Q YOY) | -69.96% | |||
| EPS Diluted (TTM) | -1.65 | |||
| EPS Diluted Growth (Q YOY) | -39.76% | |||
| Balance Sheet | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 111.00M | |||
| Cash Per Share (Q) | $2.50 | |||
| Total Current Assets (Q) | 113.07M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 73.39M | |||
| Current Ratio (Q) | 7.448 | |||
| Book Value Per Share (Q) | $1.64 | |||
| Total Assets (Q) | 126.93M | |||
| Total Current Liabilities (Q) | 15.18M | |||
| Total Debt (Q) | 37.09M | |||
| Total Liabilities (Q) | 53.54M | |||
| Total Common Equity (Q) | 73.39M | |||
| Cash Flow | HOWL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -254.00K | |||
| Cash from Financing (TTM) | 13.08M | |||
| Net Change in Cash (TTM) | -43.36M | |||
| Levered Free Cash Flow (TTM) | -34.04M | |||
| Cash from Operations (TTM) | -56.19M | |||
